Advanced Search

All Active Funding Opportunities

For questions regarding these opportunities, please contact Sarah Laye at: slaye@som.umaryland.edu.

Date Posted Organization Title Website Type LOI and/or Application Due Date Comments / Documents
02/04/22 NCI Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) Link NIH Standard due dates apply Next due date is 6/16/22. LOI not applicable.
04/10/23 NCI Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) Link NIH Standard due dates apply
09/18/20 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 - Clinical Trial Required) Link NIH Standard due dates apply
03/08/23 NCI Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Link NIH Application due: 06/17/24
08/29/23 NCI Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Link NIH Standard due dates apply
03/31/24 NCI Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention Link NIH NOSI Application due: 05/08/29
09/24/20 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies Link NIH NOSI Application due: 01/08/27
07/22/22 NCI Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Link NIH Standard due dates apply
08/11/23 NCI Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings Link NIH NOSI Application due: 11/18/25
09/18/20 NCI NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project Link NIH NOSI Application due: 05/01/25
07/08/22 NCI Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
07/27/23 NCI Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors Link NIH NOSI Application due: 10/09/24
10/14/22 NCI Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas Link NOSI Expiration Date: 5/8/23
12/13/23 NCI Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed) Link NIH Application due: 07/01/24 LOI due 30 days before application due date
08/02/22 NCI Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
07/01/22 NCI Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) Link NIH Standard due dates apply
06/26/23 NCI Notice of Special Interest (NOSI): Research on HIV-associated Malignancies Link NIH NOSI Application due: 09/08/26
03/11/24 NCI Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities Link NIH NOSI Application due: 10/10/26
08/02/22 NCI Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
10/07/22 NCI Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
12/20/22 NCI NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) Link NIH Standard due dates apply no LOI required
04/29/22 NCI Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Link NIH Standard due dates apply
07/22/22 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) Linnk NIH Standard due dates apply
04/10/23 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
10/14/22 NCI Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
12/13/23 NCI Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute's Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional) Link NIH NOSI Application due: 09/25/24
04/01/22 NCI Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Link NIH Standard due dates apply
07/22/22 NCI Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) Link NIH Standard due dates LOI due 30 days prior to the application due date.
12/13/23 NCI NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Link Foundation Application due: 06/14/24
01/17/24 NCI Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers Link NIH NOSI Application due: 07/02/25
08/11/23 NCI Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute Link NIH NOSI Application due: 11/13/24
11/28/20 NCI Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
07/27/23 NCI Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project Link NIH NOSI Application due: 05/01/25
12/13/23 NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
08/02/22 NCI Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) Link NIH Application due: 06/07/24 LOI due 30 days before application due date
04/01/22 NCI Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Link NIH Standard due dates apply Next application deadline is 6/5/22.
03/11/24 NCI Notice of Special Interest (NOSI): Telehealth Research in Cancer Care Link NIH NOSI Application due: 03/17/26
08/02/22 NCI NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Link NIH Standard due dates apply
07/22/22 NCI Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
01/09/23 NCI Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Link NIH Standard due dates apply
06/05/23 NCI Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers Link NIH NOSI Application due: 07/02/25
07/22/22 NCI The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) Link NIH Standard due dates apply
03/11/24 NCI NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Link NIH Application due: 06/14/24
07/15/22 NCI Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) Link NIH Standard due dates
12/05/22 NCI Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Link NIH Application due: 06/14/24 LOI due 30 days before application due date
10/04/23 NCI Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk Link NIH NOSI Application due: 09/08/24
04/08/22 NCI Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/04/22 NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Link NIH Standard due dates apply Next application deadline is 2/5/2023, LOI due 1/5/2023.
10/14/22 NCI Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Link NIH LOI due: 11/28/2022
03/24/23 NCI Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects Link NIH NOSI Application due: 05/09/24
04/01/22 NCI Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days prior to the application due date.
08/16/22 NCI Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Link NIH Application due: 07/29/24
03/08/23 NCI Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments Link NIH NOSI Application due: 05/08/24
01/17/24 NCI Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease Link NIH NOSI Application due: 05/10/27
08/11/23 NCI Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings Link NIH NOSI Application due: 11/18/25
03/31/24 NCI Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care Link NIH NOSI Application due: 06/05/24
09/18/20 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 No Independent Clinical Trials) Link NIH Standard due dates apply
11/28/20 NCI Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe) Link NIH NOSI Application due: 11/17/26
08/02/22 NCI Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/04/22 NCI National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
07/27/23 NCI Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects Link NIH NOSI Application due: 05/09/24
07/01/22 NCI Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
06/12/23 NCI Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) Link NIH Applications are accepted by continuous receipt.
04/02/21 NCI Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Link NIH Application due: 06/18/24
03/11/24 NCI Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) Link NIH Standard due dates apply
08/02/22 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) Link NIH Standard due dates apply
09/10/21 NCI Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) Link NIH Standard due dates apply Next due date is 10/16/21.
04/10/23 NCI Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) Link NIH Application due: 06/13/24 LOI due 30 days before application due date
09/15/22 NCI Notice of Special Interest: Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP) Link NOSI Expiration Date: 12/9/23
09/18/20 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/16/22 NCI Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Link NIH Application due: 07/29/24
07/22/22 NCI Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
01/17/24 NCI Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences Link NIH NOSI Application due: 05/08/29
08/29/23 NCI Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) Link NIH Standard due dates apply
03/31/24 NCI Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk Link NIH NOSI Application due: 05/09/26
12/13/23 NCI NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Link NIH Application due: 06/14/24